Emerging Solutions for Non-Invasive Cancer Monitoring

Sponsored by: Nuprobe

C.E. Credits: P.A.C.E. CE ｜ Florida CE

Speaker

Event Date & Time

Date: December 8, 2022

Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET)

Abstract

Liquid biopsy enables non-invasive testing and monitoring in oncology, but also comes with unique challenges. In this webinar we will discuss the current state of liquid biopsies and introduce one of our novel research technologies, Blocker Displacement Amplification (BDA), which can improve liquid biopsies. We also highlight applications of BDA in non-invasive longitudinal monitoring.

Learning Objectives

Discuss the current state, advantages, and limitations of non-invasive liquid biopsies in oncology.
Introduce Blocker Displacement Amplification (BDA), a rare allele enrichment technology with the potential to improve mutation detection from liquid biopsy.
Highlight research applications of BDA in non-invasive longitudinal monitoring.

*NuProbe’s technologies are for Research Use Only. Not for use in diagnostic procedures.

Webinars will be available for unlimited on-demand viewing after live event.

Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Emerging Solutions for Non-Invasive Cancer Monitoring

Nicholas Gallerani, PhD